Fortress Biotech Inc logo

Fortress Biotech Inc Share Price Today (NASDAQ: FBIOP)

Fortress Biotech Inc share price is $0 & ₹0.00 as on 19 Sep 2024 IST

-5.6

(-100%)

Market is closed - opens 7 PM, 12 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 20 Sep 2024

View live Fortress Biotech Inc share price in Dollar and Rupees. Guide to invest in Fortress Biotech Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Fortress Biotech Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Fortress Biotech Inc (FBIOP) Key Statistics

in dollars & INR

Previous Close
$5.605
Open
$5.69
Market Capitalization
$29.0M
Today's Volume
$48.1K
Revenue TTM
$82.6M
EBITDA
$-90.3M
Earnings Per Share (EPS)
$-0.86
Dividend Yield
41.82%
Profit Margin
-49.25%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1739.64%

How to invest in Fortress Biotech Inc Stock (FBIOP) from India?

It is very easy for Indian residents to invest directly in Fortress Biotech Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Fortress Biotech Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Fortress Biotech Inc or FBIOP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Fortress Biotech Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Fortress Biotech Inc shares which would translate to null fractional shares of Fortress Biotech Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Fortress Biotech Inc, in just a few clicks!

Global Institutional Holdings in Fortress Biotech Inc

    Analyst Recommendation on Fortress Biotech Inc

    Rating
    Trend

    Buy

      90%Buy

      9%Hold

      0%Sell

    Based on 11 Wall street analysts offering stock ratings for Fortress Biotech Inc(by analysts ranked 0 to 5 stars)

    About Fortress Biotech Inc

    Fortress Biotech, Inc., a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; Cosibelimab for metastatic cancers; Olafertinib for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and DFD-29 for the treatment of rosacea. The company's early stage product candidates include Dotinurad for gout; MB-106 for B-cell non-hodgkin lymphoma; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma; AJ201, an androgen receptor degradation enhancer; BAER-101, a positive allosteric modulator; MB-117 for newly diagnosed x-linked severe combined immunodeficiency; and MB217 for previously transplanted; and MB-110 for RAG1 severe combined immunodeficiency. Its preclinical product candidates comprise Mayo Clinic In Vivo CAR T Platform Technology; AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.
    Organization
    Fortress Biotech Inc
    Employees
    186
    CEO
    Dr. Lindsay Allan Rosenwald
    Industry
    Health Technology

    Important FAQs about investing in FBIOP Stock from India :

    Can Indians buy Fortress Biotech Inc shares?

    Yes, Indians can invest in the Fortress Biotech Inc (FBIOP) from India.

    With INDmoney, you can buy Fortress Biotech Inc at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Fortress Biotech Inc at zero transaction cost.

    How can I buy Fortress Biotech Inc shares from India?

    It is very easy to buy Fortress Biotech Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Fortress Biotech Inc (FBIOP) be purchased?

    Yes, you can buy fractional shares of Fortress Biotech Inc with INDmoney app.

    What are the documents required to start investing in Fortress Biotech Inc stocks?

    To start investing in Fortress Biotech Inc, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What is today's market capitalisation of Fortress Biotech Inc?

    Today's market capitalisation of Fortress Biotech Inc FBIOP is 29.0M

    Who is the Chief Executive Officer (CEO) of Fortress Biotech Inc ?

    Dr. Lindsay Allan Rosenwald is the current Chief Executive Officer (CEO) of Fortress Biotech Inc.